Biogen Inc
(BIIB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,913,700 | 1,224,600 | 1,573,800 | 2,326,500 | 1,308,000 |
| Marketable Securities | 1,562,200 | 2,313,400 | 2,115,200 | 2,568,600 | 2,120,500 |
| Receivables | 1,880,500 | 1,958,500 | 1,787,000 | 1,441,600 | 1,227,000 |
| Inventories | 804,200 | 929,900 | 902,700 | 1,001,600 | 893,400 |
| Other current assets | 1,221,200 | 1,214,500 | 1,494,600 | 1,393,900 | 1,151,400 |
| TOTAL | $8,381,800 | $7,640,900 | $7,873,300 | $8,732,200 | $6,700,300 |
| Non-Current Assets | |||||
| PPE Net | 3,247,300 | 3,601,200 | 3,182,400 | 2,501,800 | 2,187,600 |
| Investments And Advances | 2,660,900 | 3,066,500 | 3,488,900 | 4,165,200 | 3,868,000 |
| Intangibles | 9,285,200 | 8,826,400 | 8,512,100 | 7,477,600 | 6,748,900 |
| Other Non-Current Assets | 3,659,100 | 2,153,900 | 595,900 | 0 | 0 |
| TOTAL | $18,852,500 | $17,648,000 | $15,779,300 | $14,144,600 | $12,804,500 |
| Total Assets | $27,234,300 | $25,288,900 | $23,652,600 | $22,876,800 | $19,504,800 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 530,800 | 370,500 | 395,500 | 279,800 | 267,400 |
| Accrued Expenses | 2,765,800 | 2,861,200 | 2,901,300 | 2,903,500 | 2,096,800 |
| TOTAL | $4,863,800 | $3,295,200 | $3,368,200 | $3,419,900 | $2,577,700 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,459,000 | 5,936,500 | 5,935,000 | 6,512,700 | 6,521,500 |
| Other Non-Current Liabilities | 1,761,600 | 1,346,101 | 1,497,700 | 729,600 | 859,600 |
| TOTAL | $9,031,400 | $8,962,101 | $7,686,300 | $7,328,300 | $7,552,200 |
| Total Liabilities | $13,895,200 | $12,257,300 | $11,054,500 | $10,748,200 | $10,129,900 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 174,064 | 196,709 | 211,563 | 215,952 | 218,673 |
| Common Shares | 100 | 100 | 100 | 100 | 100 |
| Retained earnings | 16,455,400 | 16,257,000 | 15,810,400 | 15,071,600 | 12,208,400 |
| Other shareholders' equity | -139,400 | -248,500 | -333,200 | -331,100 | -221,600 |
| TOTAL | $13,339,100 | $13,031,600 | $12,598,100 | $12,128,600 | $9,374,900 |
| Total Liabilities And Equity | $27,234,300 | $25,288,900 | $23,652,600 | $22,876,800 | $19,504,800 |